Bone Metastasis Market Research Report, by Type (Osteolytic, Osteoblastic, Mixed), Diagnosis (Biopsy, Blood Test, Imaging), Treatment (Medical Therapies, Surgery, Medication), End User (Hospital, Diagnostic Centers) - Forecast Till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Bone Metastasis Market, by Type

6.1 Introduction

6.2 Osteolytic Bone Metastasis

Market Estimates & Forecast, 2020–2027

6.3 Osteoblastic Bone Metastasis

Market Estimates & Forecast, 2020–2027

6.4 Mixed Bone Metastasis

Market Estimates & Forecast, 2020–2027

6.5 Others

Chapter 7. Global Bone Metastasis Market, by Diagnosis

7.1 Introduction

7.2 Biopsy

Market Estimates & Forecast, 2020–2027

7.3 Blood Test

Market Estimates & Forecast, 2020–2027

7.4 Imaging

Market Estimates & Forecast, 2020–2027

7.4.1 X-ray

7.4.2 Bone Scintigraphy

7.4.3 Computerized Tomography

7.4.4 Magnetic Resonance Imaging

7.4.5 Positron Emission Tomography

7.4.6 Others

7.5 Others

Chapter 8. Global Bone Metastasis Market, by Treatment

8.1 Introduction

8.2 Medical Therapies

Market Estimates & Forecast, 2020–2027

8.2.1 Chemotherapy

8.2.2 Targeted therapy

8.2.3 Hormone therapy

8.2.4 Ablation Therapy

Market Estimates & Forecast, 2020–2027

8.2.4.1 Radiofrequency Ablation

8.2.4.2 Cryoablation

8.2.4.3 Others

8.2.5 Others

8.3 Surgery

Market Estimates & Forecast, 2020–2027

8.3.1 Vertebroplasty

8.3.2 Kyphoplasty

8.4 Medication

Market Estimates & Forecast, 2020–2027

8.4.1 Pain Medications

Market Estimates & Forecast, 2020–2027

8.4.1.1 Ibuprofen

8.4.1.2 Morphine

8.4.1.3 Others

8.4.2 Bone-Building Medications

Market Estimates & Forecast, 2020–2027

8.4.2.1 Corticosteroids

8.4.2.2 Bisphosphonates

Market Estimates & Forecast, 2020–2027

8.4.2.2.1 Teriparatide

8.4.2.2.2 Pamidronate

8.4.2.2.3 Medronate

8.5 Others

Chapter 9. Global Bone Metastasis Market, by End-User

9.1 Introduction

9.2 Hospital & Clinics

Market Estimates & Forecast, 2020–2027

9.3 Diagnostic Centers

Market Estimates & Forecast, 2020–2027

9.4 Pharmacies

Market Estimates & Forecast, 2020–2027

9.5 Ambulatory Surgical Centers

Market Estimates & Forecast, 2020–2027

9.6 Others

Chapter 10. Global Bone Metastasis Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 F. Hoffmann-La Roche Ltd

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 Bayer AG

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Merck & Co., Inc.

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Pfizer Inc.

12.4.1 Company Overview

12.4.2 Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Novartis AG

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Pharmalucence Inc.

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Koninklijke Philips N.V.

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 GENERAL ELECTRIC

12.8.1 Overview

12.8.2 Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Siemens AG

12.9.1 Overview

12.9.2 Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 TOSHIBA CORPORATION

12.10.1 Overview

12.10.2 Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Bone Metastasis Market

Chapter 14 Appendix

LIST OF TABLES

Table 1 Bone Metastasis Industry Synopsis, 2020–2027

Table 2 Global Bone Metastasis Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Global Bone Metastasis Market, by Region, 2020–2027, (USD Million)

Table 4 Global Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 5 Global Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 6 Global Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 7 Global Bone Metastasis Market, by End-User, 2020–2027, (USD Million

Table 8 North America Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 9 North America Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 10 North America Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 11 North America Bone Metastasis Market, by End-User, 2020–2027, (USD Million)

Table 12 U.S. Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 13 U.S. Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 14 U.S. Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 15 U.S. Bone Metastasis Market, by End-User, 2020–2027, (USD Million)

Table 16 Canada Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 17 Canada Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 18 Canada Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 19 Canada Bone Metastasis Market, by End-User, 2020–2027, (USD Million)

Table 20 South America Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 21 South America Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 22 South America Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 23 South America Bone Metastasis Market, by End-User, 2020–2027, (USD Million)

Table 24 Europe Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 25 Europe Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 26 Europe Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 27 Europe Bone Metastasis Market, by End-User, 2020–2027, (USD Million)

Table 28 Western Europe Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 29 Western Europe Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 30 Western Europe Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 31 Western Europe Bone Metastasis Market, by End-User, 2020–2027, (USD Million)

Table 32 Eastern Europe Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 33 Eastern Europe Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 34 Eastern Europe Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 35 Eastern Europe Bone Metastasis Market, by End-User, 2020–2027, (USD Million)

Table 36 Asia Pacific Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 37 Asia Pacific Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 38 Asia Pacific Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 39 Asia Pacific Bone Metastasis Market, by End-User, 2020–2027, (USD Million)

Table 40 The Middle East & Africa Bone Metastasis Market, by Type, 2020–2027, (USD Million)

Table 41 The Middle East & Africa Bone Metastasis Market, by Diagnosis, 2020–2027, (USD Million)

Table 42 The Middle East & Africa Bone Metastasis Market, by Treatment, 2020–2027, (USD Million)

Table 43 The Middle East & Africa Bone Metastasis Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Bone Metastasis Market

Figure 3 Market Dynamics for Global Bone Metastasis Market

Figure 4 Global Bone Metastasis Market Share, by Type 2020

Figure 5 Global Bone Metastasis Market Share, by Diagnosis 2020

Figure 6 Global Bone Metastasis Market Share, by Treatment, 2020

Figure 7 Global Bone Metastasis Market Share, by End-User, 2020

Figure 8 Global Bone Metastasis Market Share, by Region, 2020

Figure 9 North America Bone Metastasis Market Share, by Country, 2020

Figure 10 Europe Bone Metastasis Market Share, by Country, 2020

Figure 11 Asia Pacific Bone Metastasis Market Share, by Country, 2020

Figure 12 The Middle East & Africa Bone Metastasis Market Share, by Country, 2020

Figure 13 Global Bone Metastasis Market: Company Share Analysis, 2020 (%)

Figure 14 F. Hoffmann-La Roche Ltd: Key Financials

Figure 15 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 16 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 17 Bayer AG: Key Financials

Figure 18 Bayer AG: Segmental Revenue

Figure 19 Bayer AG: Geographical Revenue

Figure 20 Merck & Co., Inc.: Key Financials

Figure 21 Merck & Co., Inc.: Segmental Revenue

Figure 22 Merck & Co., Inc.: Geographical Revenue

Figure 23 Pfizer Inc.: Key Financials

Figure 24 Pfizer Inc.: Segmental Revenue

Figure 25 Pfizer Inc.: Geographical Revenue

Figure 26 Novartis AG: Key Financials

Figure 27 Novartis AG: Segmental Revenue

Figure 28 Novartis AG: Geographical Revenue

Figure 29 Pharmalucence Inc.: Key Financials

Figure 30 Pharmalucence Inc.: Segmental Revenue

Figure 31 Pharmalucence Inc.: Geographical Revenue

Figure 32 Koninklijke Philips N.V.: Key Financials

Figure 33 Koninklijke Philips N.V.: Segmental Revenue

Figure 34 Koninklijke Philips N.V.: Geographical Revenue

Figure 35 GENERAL ELECTRIC: Key Financials

Figure 36 GENERAL ELECTRIC: Segmental Revenue

Figure 37 GENERAL ELECTRIC: Geographical Revenue

Figure 38 Siemens AG: Key Financials

Figure 39 Siemens AG: Segmental Revenue

Figure 40 Siemens AG: Geographical Revenue

Figure 41 TOSHIBA CORPORATION: Key Financials

Figure 42 TOSHIBA CORPORATION: Segmental Revenue

Figure 43 TOSHIBA CORPORATION: Geographical Revenue